Getinge AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Getinge AB Comments on FY 2013 Financial Guidance
Getinge AB announced that its fiscal year 2013 organic volume growth is expected to remain in line with that of fiscal year 2012 or possibly somewhat better. Fiscal year 2013 profit growth, excluding restructuring costs, is expected to be favorable, even in consideration of the introduction of the Medical Device Tax in the United States at year-end 2012 and negative transaction effects, which, when combined, are expected to total SEK 230 million.
Latest Developments for Getinge AB
- Getinge AB lowers FY 2014 financial outlook
- Pulsion Medical Systems SE and indirect subsidiary of Getinge AB, MAQUET, to enter into domination and profit and loss transfer agreement
- Getinge AB issues Q1 2014 profit outlook below analysts' estimates
- Getinge finalizes acquisition of Pulsion Medical Systems
Latest Key Developments in Medical
- Share this
- Digg this